Cargando…

Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey

BACKGROUND: Physicians can improve their relationships with patients by understanding and meeting patients’ treatment targets, leading to higher adherence to therapy and improved disease prognosis. In the current study, we performed a questionnaire-based survey to further understand treatment target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuken, Philipp A., Grunert, Philip C., Lügering, Andreas, Teich, Niels, Stallmach, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675909/ https://www.ncbi.nlm.nih.gov/pubmed/33240395 http://dx.doi.org/10.1177/1756284820971213

Ejemplares similares

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
por: Teich, Niels, et al.
Publicado: (2022)

An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective
por: Schmidt, Carsten, et al.
Publicado: (2021)

Fatigue in patients with inflammatory bowel disease—strongly influenced by depression and not identifiable through laboratory testing: a cross-sectional survey study
por: Uhlir, Victoria, et al.
Publicado: (2023)

The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families
por: Reinsch, Steffen, et al.
Publicado: (2021)

Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases—LISTEN 1
por: Teich, Niels, et al.
Publicado: (2021)

Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study
por: Schmidt, Carsten, et al.
Publicado: (2022)

COVID-19 und chronisch-entzündliche Darmerkrankungen
por: Teich, Niels, et al.
Publicado: (2023)

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
por: Quickert, Stefanie, et al.
Publicado: (2023)

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease
por: Stallhofer, Johannes, et al.
Publicado: (2023)

Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review
por: Terjung, Birgit, et al.
Publicado: (2020)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity
por: Teich, Niels, et al.
Publicado: (2016)

Medical Therapy of Active Ulcerative Colitis
por: Bürger, Martin, et al.
Publicado: (2015)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Lamprecht, Georg, et al.
Publicado: (2015)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
por: Stallmach, Andreas, et al.
Publicado: (2020)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Giszas, Benjamin, et al.
Publicado: (2022)

Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study
por: Coldewey, Sina M., et al.
Publicado: (2022)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study
por: Schmidt, C., et al.
Publicado: (2016)

Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors
por: Voss, Andreas, et al.
Publicado: (2022)

Electrical Impedance Tomography (EIT) in a Patient Suffering from Post-COVID Syndrome with Dyspnea: A Case Report
por: Katzer, Katrin, et al.
Publicado: (2022)

Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
por: Kozik, Valeska, et al.
Publicado: (2023)

Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series
por: Giszas, Benjamin, et al.
Publicado: (2022)

Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography
por: Gremme, Yvonne, et al.
Publicado: (2023)

Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Therapie chronisch entzündlicher Darmerkrankungen in der COVID-19-Pandemie
por: Grunert, Philip C., et al.
Publicado: (2020)

Beyond endoscopic assessment in inflammatory bowel disease: real-time histology of disease activity by non-linear multimodal imaging
por: Chernavskaia, Olga, et al.
Publicado: (2016)

Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
por: Horn, Paul, et al.
Publicado: (2018)

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
por: Stallhofer, Johannes, et al.
Publicado: (2022)

Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen
por: Stallmach, Andreas, et al.
Publicado: (2022)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation
por: Ibidapo-obe, Oluwatomi, et al.
Publicado: (2020)

Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results from a Phase-3 Clinical Trial Program
por: Gasche, Christoph, et al.
Publicado: (2014)

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u0p506db55dhufm72rgdacjeek